BC, OCN, ONN-CG, an oncology nurse navigator and clinical advocate at Hackensack Meridian Ocean University Medical Center, shared insights from her 50-year career in nursing — 36 of which have been ...

Pamela Plasket, RN, discusses the evolving role of oncology nurses as lung cancer patients survive longer on advanced therapies like BiTEs. The landscape of thoracic oncology is undergoing a ...

Hughes discusses managing GI toxicities and the need for research regarding GLP-1 use among breast cancer patients and ...

Oncology Nursing News connects oncology nurses and APPs with updates on therapy advances, side effect management, and patient-centered cancer care.

Please check back later for more content.

The FDA approved Tregzi, a precision-engineered cell therapy, to improve chronic GVHD-free survival in adults undergoing allogeneic transplant. The FDA approved Azurity’s Aprepitant Injectable ...

The FDA approved Azurity’s Aprepitant Injectable Emulsion, a polysorbate-80-free, ready-to-use IV option for preventing chemotherapy-induced nausea. The U.S. Food and Drug Administration (FDA) has ...

Oncology nurses can guide patients through the rationale and implications of this decision. Oncology nurses frequently address patient questions regarding unconventional or repurposed therapies, ...

The FDA approved Tregzi, a precision-engineered cell therapy, to improve chronic GVHD-free survival in adults undergoing allogeneic transplant. The U.S. Food and Drug Administration (FDA) has approved ...

The core of this optimization strategy is the geriatric assessment. At Mount Sinai, Jakubowski noted that patients aged 65 and older — and in some cases, those 60 and older — receive a comprehensive ...

Nursing Insights: Dato-DXd Delays Subsequent Therapy in 1L Metastatic TNBC ...

New research finds younger generations age faster biologically, increasing risks for early-onset lung, colorectal, and other solid tumor cancers. The paradigm of oncology is shifting as clinicians ...